Delivery Order SPE2DB22D3501-SPE2DB26FTF51
- Not listed
- The Defense Logistics Agency awarded a $1,315.62 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Estradiol 0.01% Cream in 42.5 gram units. This non-set-aside contract represents a single delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The point of performance is located at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Estradiol 0.01% Cream in 42.5-gram units. This is a firm fixed-price delivery order with a ceiling value of $1,563.30, with an ultimate completion date of September 17, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this order,...
- The Defense Logistics Agency awarded a delivery order valued at $1,072.08 to AmerisourceBergen Drug Corp for the supply of Estradiol 0.01% cream in 42.5-gram quantities. This firm fixed-price delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,817.31 for Estradiol 0.01% Cream (42.5 grams) on May 2, 2025, with completion scheduled for May 5, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $1,864.28 to AmerisourceBergen Drug Corp for the supply of Estradiol 0.01% cream in 42.5-gram quantities. This firm fixed-price contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreements with the agency. The award utilized no set-aside designation, indicating competitive selection among...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Estradiol 0.01% Cream (42.5GM) on September 19, 2025, with a ceiling value of $1,114.92 and an ultimate completion date of September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $6,211.59 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Estradiol 0.01% cream in 42.5-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Estradiol 0.01% cream in 42.5 gram units, with a ceiling value of $3,720.99 and an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $4,926.28 delivery order to AmerisourceBergen Drug Corp for Estradiol 0.01% cream (42.5 grams) on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Estradiol 0.01% Cream in 42.5 gram quantities. This firm fixed-price delivery order, valued at $1,255.56, represents a non-competitive set-aside transaction and is scheduled for completion by August 26, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTF51Delivery Order
The Defense Logistics Agency (DLA) awarded a $1,630.04 delivery order to AmerisourceBergen Drug Corp for the supply of Estradiol 0.01% Cream in 42.5-gram quantities. This contract, awarded on October 23, 2025, with an ultimate completion date of October 24, 2025, represents a firm fixed-price delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen's existing SPE2DX Indefinite Delivery/Indefinite Quantity contract with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of medications, medical supplies, and healthcare commodities to military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical needs across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/23/25 |